Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®

PHASE2CompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Formoterol

Formoterol Turbuhaler 9 μg and Placebo Diskus

DRUG

Salmeterol

Salmeterol Diskus 50 μg and Placebo Turbuhaler

DRUG

Placebo

Placebo Diskus and Placebo Turbuhaler

Trial Locations (17)

Unknown

Research Site, Bussolengo

Research Site, Cassano delle Murge

Research Site, Catanzaro

Research Site, Cava de' Tirreni

Research Site, Napoli

Research Site, Palermo

Research Site, Parma

Research Site, Pisa

Research Site, Prato

Research Site, Roma

Research Site, Barcelona

Research Site, Madrid

Research Site, Málaga

Research Site, Gothenburg

Research Site, Linköping

Research Site, Luleå

Research Site, Lund

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY